Evidence map›Paper›PMID 37676724›Full record

ArticleThe Journal of clinical investigation2023

Dietary potassium stimulates Ppp1Ca-Ppp1r1a dephosphorylation of kidney NaCl cotransporter and reduces blood pressure.

P Richard Grimm, Anamaria Tatomir, Lena L Rosenbaek, Bo Young Kim, Dimin Li, Eric J Delpire, Robert A Fenton, Paul A Welling

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Mechanistic target of rapamycin complex-1 plays a role in inhibiting kidney KAmerican journal of physiology. Renal physiology · 2026
    Article
  7. Article
  8. Potassium and the kidney.Nature reviews. Nephrology · 2026
    Review
  9. New evidence linking lifestyle factors to blood pressure: Focus on 2024 findings.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  10. How Does Dietary Potassium Influence BP?Journal of the American Society of Nephrology : JASN · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. mTORc2 in Distal Convoluted Tubule and Renal K + Excretion during High Dietary K + Intake.Journal of the American Society of Nephrology : JASN · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

P Richard GrimmDepartment of Medicine (Nephrology), Johns Hopkins University School of Medicine Baltimore, Maryland, USA.
Anamaria TatomirDepartment of Medicine (Nephrology), Johns Hopkins University School of Medicine Baltimore, Maryland, USA.
Lena L RosenbaekThe LeDucq Potassium in Hypertension Research Network of Excellence is detailed in Supplemental Acknowledgments.
Bo Young KimDepartment of Medicine (Nephrology), Johns Hopkins University School of Medicine Baltimore, Maryland, USA.
Dimin LiDepartment of Medicine (Nephrology), Johns Hopkins University School of Medicine Baltimore, Maryland, USA.
Eric J DelpireThe LeDucq Potassium in Hypertension Research Network of Excellence is detailed in Supplemental Acknowledgments.
Robert A FentonThe LeDucq Potassium in Hypertension Research Network of Excellence is detailed in Supplemental Acknowledgments.
Paul A WellingDepartment of Medicine (Nephrology), Johns Hopkins University School of Medicine Baltimore, Maryland, USA.
Johns Hopkins University · USAarhus University · DKPotato Research Institute · CZ

Funding

WNK-SPAK signaling in the Distal NephronR01DK093501 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eric J Delpire, Paul A Welling · 2012 to 2026
$12.1M
Molecular of ROMK Channel FunctionR01DK054231 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI Paul A Welling · 1998 to 2026
$7.7M
OXGR1 in Renal Intercalated Cells, Salt Transport and Diuretic EfficacyR01DK110375 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eric J Delpire, SUSAN MARIE WALL · 2017 to 2026
$6.7M
Molecular Mechanism of ROMK Channel FunctionR56DK054231 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI WELLING, PAUL A · 2022 to 2022
$100k
NIDDK NIH HHS R01 DK054231NIDDK NIH HHS R01 DK093501NIDDK NIH HHS R01 DK110375NIDDK NIH HHS R56 DK054231
6 · The paper itself

Abstract

Consumption of low dietary potassium, common with ultraprocessed foods, activates the thiazide-sensitive sodium chloride cotransporter (NCC) via the with no (K) lysine kinase/STE20/SPS1-related proline-alanine-rich protein kinase (WNK/SPAK) pathway to induce salt retention and elevate blood pressure (BP). However, it remains unclear how high-potassium "DASH-like" diets (dietary approaches to stop hypertension) inactivate the cotransporter and whether this decreases BP. A transcriptomics screen identified Ppp1Ca, encoding PP1A, as a potassium-upregulated gene, and its negative regulator Ppp1r1a, as a potassium-suppressed gene in the kidney. PP1A directly binds to and dephosphorylates NCC when extracellular potassium is elevated. Using mice genetically engineered to constitutively activate the NCC-regulatory kinase SPAK and thereby eliminate the effects of the WNK/SPAK kinase cascade, we confirmed that PP1A dephosphorylated NCC directly in a potassium-regulated manner. Prior adaptation to a high-potassium diet was required to maximally dephosphorylate NCC and lower BP in constitutively active SPAK mice, and this was associated with potassium-dependent suppression of Ppp1r1a and dephosphorylation of its cognate protein, inhibitory subunit 1 (I1). In conclusion, potassium-dependent activation of PP1A and inhibition of I1 drove NCC dephosphorylation, providing a mechanism to explain how high dietary K+ lowers BP. Shifting signaling of PP1A in favor of activation of WNK/SPAK may provide an improved therapeutic approach for treating salt-sensitive hypertension.

Indexed as

HypertensionProtein Serine-Threonine KinasesAnimalsBlood PressureKidneyMicePhosphorylationPotassiumPotassium, DietarySodium ChlorideSolute Carrier Family 12, Member 3PotassiumPotassium, DietaryProtein Serine-Threonine KinasesSodium ChlorideSolute Carrier Family 12, Member 3HypertensionNephrologyPhosphoprotein phosphatasesTransport

Identifiers

PMID37676724
PMCPMC10617769
OpenAlexW4386498796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.